News & Press Release
2004
- All Categories
- Announcements
- HR and Organization
- Product Information
-
- 2004-12-01 Product Information IKH-01 (Low-dose pill)／Collaboration formed with Japan Medical Association regarding procurement of clinical trial contracting facilities
- 2004-11-01 Product Information IKH-01 (Low-dose pill)／Commencement of Phase III trial and long-term administration trial (IND filed in November)
- 2004-11-01 Product Information IKH-01 (Low-dose pill)／Conclusion of Phase III preliminary trial
- 2004-11-01 Product Information NPC-02 (Zinc preparation)／Orphan drug designation
- 2004-11-01 Product Information NPC-03 (i.v. Phenobarbital)／Designated as priority face-to-face advice product by the Pharmaceuticals and Medical Devices Agency
- 2004-10-01 Product Information NPC-03 (i.v. Phenobarbital)／Physician-oriented clinical trials (October: Nattonal project. Full cooperation as investigational new drug supplier)
- 2004-08-01 Product Information NPC-02 (Zinc preparation)／Commencement of Phase III trial (IND filed in August)
- 2004-05-01 Product Information NPC-02 (Zinc preparation)／Post PIIb face-to-face consultation with Pharmaceuticals and Medical Devices Agency.
- 2004-04-01 Product Information IKH-01 (Low-dose pill)／License agreement with Janssen Pharmaceutical K.K. (Johnson & Johnson)
- 2004-04-01 Product Information NPC-02 (Zinc preparation)／License agreement with Teva Pharmaceuticals USA
- 2004-03-01 Product Information NPC-02 (Zinc preparation)／Collaboration formed with Japan Medical Association regarding procurement of clinical trial contracting facilities